Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
HIV
New assay developed for persistent African HIV strains
By
LabPulse.com staff writers
A multinational research team has developed a test to measure the persistence of HIV in people who have been infected by strains of the virus found predominantly in Africa, providing a necessary tool in the search for a cure for HIV.
July 9, 2024
HIV vaccine trial begins enrollment in U.S., South Africa
By
LabPulse.com staff writers
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Test detects viruses in blooddrop, expands screening of HIV and hepatitis
By
Nick Paul Taylor
The nucleic acid amplification test method begins with the collection of whole blood from a finger on a Proteinsaver card -- a kit for protein collection, transport, and storage.
April 13, 2023
Targeted HIV testing in hospitals may increase diagnoses, Spanish study finds
By
Elissa Wolfson
The implementation of targeted testing for HIV in hospital emergency departments may lead to a significant increase in HIV diagnoses.
April 10, 2023
STI, HIV screening decreased during COVID-19 as cases increased
By
Elissa Wolfson
Testing for sexually transmitted infections and HIV declined during the pandemic despite increased cases, particularly in so-called safety net hospitals.
March 31, 2023
Biolytical Laboratories nabs Health Canada authorization for HIV-1/2 syphilis antibody test
By
LabPulse.com staff writers
The test detects HIV-1, HIV-2, and syphilis antibodies using a sample and fingerprick, delivering results in one minute or less.
March 27, 2023
Birmingham AIDS Outreach, Binx Health launch accessible HIV/STI testing program in Alabama
By
LabPulse.com staff writers
The program will serve the Birmingham, AL, metro area by providing access to self-collection kits for HIV and sexually transmitted infections (STIs) through a network of trusted partners that work with higher-risk populations.
March 1, 2023
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
By
Maryam Payne
The public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.
February 28, 2023
Chembio Diagnostics obtains FDA CLIA waiver for HIV-syphilis testing system
By
LabPulse.com staff writers
More than 200,000 CLIA-waived point-of-care testing sites in the U.S. can now use the system to detect HIV and syphilis, Richard Eberly, Chembio’s president and CEO, said in a statement.
February 24, 2023
Maternova, MedMira ink agreement to market rapid diagnostic tests for HIV, syphilis, hepatitis
By
LabPulse.com staff writers
MedMira's Multiplo TP/HIV rapid test delivers 100% sensitivity in identifying co-infections and is helping to reduce mother-to-child transmission of syphilis and HIV, the firms said.
February 21, 2023
Thermo Fisher Scientific launches sequencing assay to ID variants that may resist HIV therapies
By
LabPulse.com staff writers
The assay, which uses HIV RNA extracted from plasma or dried blood spots, is designed to analyze genomic mutations in the protease, reverse transcriptase, and integrase regions of the HIV-1 pol gene across nine subtypes of global significance.
January 24, 2023
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
By
LabPulse.com staff writers
Using a small blood sample, the test detects antibodies for HIV types 1 and 2 as well as Treponema pallidum, the bacteria that causes syphilis.
November 28, 2022
Page 1 of 4
Next Page
